Related Experiment Video
Updated: May 14, 2026
15:05
Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
KIT-D816V oncogenic activity is controlled by the juxtamembrane docking site Y568-Y570
A Chaix1, M-L Arcangeli1, S Lopez1
11] INSERM, U1068, Centre de Recherche en Cancérologie de Marseille, Marseille, France [2] Institut Paoli-Calmettes, Marseille, France [3] Aix-Marseille University, Marseille, France.
Oncogene
|February 19, 2013
Summary
The KIT-D816V mutation in mastocytosis has limited transforming potential due to negative regulation by an intracellular docking site. Mutating this site enhances KIT-D816V
Area of Science:
- Oncology
- Molecular Biology
- Signal Transduction
Background:
- The KIT receptor tyrosine kinase, particularly the D816V mutation, is implicated in mastocytosis and other cancers.
- While KIT mutations are oncogenic drivers, KIT-D816V appears less aggressive than other KIT mutants.
- Understanding the regulatory mechanisms of KIT-D816V is crucial for targeted cancer therapies.
Purpose of the Study:
- To investigate the regulatory role of an intracellular docking site in the juxtamembrane region of KIT on the transforming potential of the KIT-D816V mutant.
- To identify signaling proteins interacting with this docking motif and elucidate their functional consequences.
Main Methods:
- Investigated the interaction of signaling proteins with the juxtamembrane docking site of KIT.
- Assessed the impact of mutating this docking site on KIT-D816V signaling, gene expression, and transforming activity.
- Compared the effects of docking site mutations on KIT-D816V with those on wild-type KIT and FLT3-ITD.
Main Results:
- An intracellular docking site negatively regulates the transforming potential of the KIT-D816V mutant.
- Sixteen signaling proteins were identified to interact with this juxtamembrane motif.
- Mutation of the docking site led to altered signaling, gene expression, and increased transforming activity of KIT-D816V, contrary to effects on WT KIT or FLT3-ITD.
Conclusions:
- The KIT-D816V mutation confers only partial transforming properties, acting as a mild oncogenic event.
- An intracellular docking site plays a critical role in modulating KIT-D816V oncogenicity.
- Additional mutations are likely required for KIT-D816V to achieve its full transforming potential in cancer development.
Related Concept Videos
01:26Receptor Tyrosine Kinases
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
01:16In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
02:38S-Cdk Initiates DNA Replication
The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of replication.
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of replication.
02:38S-Cdk Initiates DNA Replication
The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of replication.
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of replication.
02:31Homologous Recombination
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...